UK markets close in 4 hours 3 minutes

Haleon plc (HLN.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
323.20-0.55 (-0.17%)
As of 12:11PM GMT. Market open.
Full screen
Previous close323.75
Open325.20
Bid323.20 x N/A
Ask323.35 x N/A
Day's range322.20 - 326.35
52-week range306.50 - 357.65
Volume1,073,772
Avg. volume19,779,244
Market cap29.846B
Beta (5Y monthly)N/A
PE ratio (TTM)24.86
EPS (TTM)0.13
Earnings date02 Nov 2023
Forward dividend & yield0.04 (1.11%)
Ex-dividend date24 Aug 2023
1y target est359.75
  • GlobeNewswire

    Health exclusion affects more than three in five people globally

    Year 2 Health Inclusivity Index Scores Under phase two of the Health Inclusivity Index, Australia achieves the highest score, followed by Sweden, UK, USA, France, Israel, Canada, South Korea, Germany, Switzerland and Thailand Phase two of Economist Impact’s Health Inclusivity Index, supported by Haleon, measures experience of health inclusion across 42,000 people in 40 countriesHealth inclusivity scores fall worldwide with addition of lived experience data, exposing glaring policy-practice gap i

  • Globe Newswire

    UK falls to third place in global Health Inclusivity Index

    Year 2 Health Inclusivity Scores Under phase two of the Health Inclusivity Index, Australia achieves the highest score, followed by Sweden, UK, USA, France, Israel, Canada, South Korea, Germany, Switzerland and Thailand More than three in five (63%) people in the UK experience barriers to health inclusionPeople in UK, Canada and France face the longest waiting times to see a GPHealth inclusivity scores fall worldwide with addition of lived experience data in Economist Impact’s Health Inclusivity

  • PR Newswire

    Britain falls from top spot in Economist Impact's latest Health Inclusivity Index

    Economist Impact, an arm of The Economist Group that works with organisations globally to further their missions, today launched phase two of the Health Inclusivity Index, supported by Haleon (LSE / NYSE: HLN), a global leader in consumer health. This phase's results show health inclusivity falling worldwide, and notably Britain falling from its top spot in phase one.